| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.04e-05 | 188 | 80 | 7 | GO:0005201 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A3 CCN5 THBS1 HMCN1 ADAMTS3 ADAMTS7 SBSPON NCAN ADAMTS18 PAPLN CFP USH2A SSPOP | 1.48e-07 | 656 | 79 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A3 CCN5 THBS1 HMCN1 ADAMTS3 ADAMTS7 SBSPON NCAN ADAMTS18 PAPLN CFP USH2A SSPOP | 1.54e-07 | 658 | 79 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A3 THBS1 HMCN1 ADAMTS3 SBSPON NCAN PAPLN CFP USH2A SSPOP | 4.78e-06 | 530 | 79 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 9.95e-05 | 122 | 79 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.09e-04 | 6 | 79 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | stereocilium membrane | 2.09e-04 | 6 | 79 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.89e-04 | 8 | 79 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 3.89e-04 | 8 | 79 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 3.89e-04 | 8 | 79 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.61e-03 | 332 | 79 | 6 | GO:0005788 | |
| MousePheno | abnormal CD4-positive, gamma-delta intraepithelial T cell morphology | 2.00e-05 | 2 | 63 | 2 | MP:0008357 | |
| MousePheno | decreased CD4-positive, gamma-delta intraepithelial T cell number | 2.00e-05 | 2 | 63 | 2 | MP:0008359 | |
| Domain | TSP_1 | CCN5 THBS1 HMCN1 ADAMTS3 ADAMTS7 SBSPON ADAMTS18 PAPLN CFP ISM2 SSPOP | 2.24e-15 | 63 | 80 | 11 | PF00090 |
| Domain | TSP1 | CCN5 THBS1 HMCN1 ADAMTS3 ADAMTS7 SBSPON ADAMTS18 PAPLN CFP ISM2 SSPOP | 3.24e-15 | 65 | 80 | 11 | SM00209 |
| Domain | TSP1_rpt | CCN5 THBS1 HMCN1 ADAMTS3 ADAMTS7 SBSPON ADAMTS18 PAPLN CFP ISM2 SSPOP | 3.24e-15 | 65 | 80 | 11 | IPR000884 |
| Domain | TSP1 | CCN5 THBS1 HMCN1 ADAMTS3 ADAMTS7 SBSPON ADAMTS18 PAPLN CFP ISM2 SSPOP | 3.24e-15 | 65 | 80 | 11 | PS50092 |
| Domain | PLAC | 1.15e-06 | 19 | 80 | 4 | PS50900 | |
| Domain | PLAC | 1.15e-06 | 19 | 80 | 4 | IPR010909 | |
| Domain | ADAM_spacer1 | 2.60e-06 | 23 | 80 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.60e-06 | 23 | 80 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.11e-06 | 24 | 80 | 4 | IPR013273 | |
| Domain | VWFC_1 | 1.66e-05 | 36 | 80 | 4 | PS01208 | |
| Domain | VWC | 2.06e-05 | 38 | 80 | 4 | SM00214 | |
| Domain | VWFC_2 | 2.06e-05 | 38 | 80 | 4 | PS50184 | |
| Domain | VWF_dom | 3.09e-05 | 42 | 80 | 4 | IPR001007 | |
| Domain | CTDL_fold | 9.60e-05 | 107 | 80 | 5 | IPR016187 | |
| Domain | - | 1.83e-04 | 26 | 80 | 3 | 1.25.40.90 | |
| Domain | VWC | 2.29e-04 | 28 | 80 | 3 | PF00093 | |
| Domain | ENTH_VHS | 2.55e-04 | 29 | 80 | 3 | IPR008942 | |
| Domain | C4 | 2.69e-04 | 6 | 80 | 2 | SM00111 | |
| Domain | - | 2.69e-04 | 6 | 80 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.69e-04 | 6 | 80 | 2 | IPR001442 | |
| Domain | ENTH | 2.69e-04 | 6 | 80 | 2 | PF01417 | |
| Domain | C4 | 2.69e-04 | 6 | 80 | 2 | PF01413 | |
| Domain | NC1_IV | 2.69e-04 | 6 | 80 | 2 | PS51403 | |
| Domain | Peptidase_M12B_N | 6.19e-04 | 39 | 80 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.19e-04 | 39 | 80 | 3 | PF01562 | |
| Domain | ENTH | 6.40e-04 | 9 | 80 | 2 | PS50942 | |
| Domain | ENTH | 6.40e-04 | 9 | 80 | 2 | SM00273 | |
| Domain | DISINTEGRIN_1 | 6.67e-04 | 40 | 80 | 3 | PS00427 | |
| Domain | Reprolysin | 6.67e-04 | 40 | 80 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 6.67e-04 | 40 | 80 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 6.67e-04 | 40 | 80 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 6.67e-04 | 40 | 80 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 7.17e-04 | 41 | 80 | 3 | IPR001762 | |
| Domain | EGF_1 | 7.89e-04 | 255 | 80 | 6 | PS00022 | |
| Domain | ENTH | 7.97e-04 | 10 | 80 | 2 | IPR013809 | |
| Domain | ZINC_PROTEASE | 8.31e-04 | 98 | 80 | 4 | PS00142 | |
| Domain | Unchr_dom_Cys-rich | 1.37e-03 | 13 | 80 | 2 | IPR014853 | |
| Domain | C8 | 1.37e-03 | 13 | 80 | 2 | SM00832 | |
| Domain | PLAC | 1.59e-03 | 14 | 80 | 2 | PF08686 | |
| Domain | TIL_dom | 1.59e-03 | 14 | 80 | 2 | IPR002919 | |
| Domain | Ig_V-set | 1.64e-03 | 199 | 80 | 5 | IPR013106 | |
| Domain | EGF_CA | 1.87e-03 | 122 | 80 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.98e-03 | 124 | 80 | 4 | IPR001881 | |
| Domain | VWD | 2.09e-03 | 16 | 80 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.09e-03 | 16 | 80 | 2 | IPR001846 | |
| Domain | VWFD | 2.09e-03 | 16 | 80 | 2 | PS51233 | |
| Domain | VWD | 2.09e-03 | 16 | 80 | 2 | PF00094 | |
| Domain | UIM | 2.65e-03 | 18 | 80 | 2 | PF02809 | |
| Domain | VWC_out | 2.96e-03 | 19 | 80 | 2 | SM00215 | |
| Domain | EGF_3 | 3.38e-03 | 235 | 80 | 5 | PS50026 | |
| Domain | EGF | 3.38e-03 | 235 | 80 | 5 | SM00181 | |
| Domain | UIM | 3.61e-03 | 21 | 80 | 2 | SM00726 | |
| Domain | IGv | 4.09e-03 | 75 | 80 | 3 | SM00406 | |
| Domain | Growth_fac_rcpt_ | 4.53e-03 | 156 | 80 | 4 | IPR009030 | |
| Domain | UIM | 4.70e-03 | 24 | 80 | 2 | PS50330 | |
| Domain | C_TYPE_LECTIN_1 | 4.91e-03 | 80 | 80 | 3 | PS00615 | |
| Domain | MetalloPept_cat_dom | 5.08e-03 | 81 | 80 | 3 | IPR024079 | |
| Domain | - | 5.08e-03 | 81 | 80 | 3 | 3.40.390.10 | |
| Domain | UIM_dom | 5.10e-03 | 25 | 80 | 2 | IPR003903 | |
| Domain | EGF_2 | 5.61e-03 | 265 | 80 | 5 | PS01186 | |
| Domain | Lectin_C | 5.62e-03 | 84 | 80 | 3 | PF00059 | |
| Domain | CLECT | 5.62e-03 | 84 | 80 | 3 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 5.81e-03 | 85 | 80 | 3 | PS50041 | |
| Domain | C-type_lectin-like | 6.00e-03 | 86 | 80 | 3 | IPR001304 | |
| Domain | EGF_CA | 6.00e-03 | 86 | 80 | 3 | PF07645 | |
| Domain | TRYPSIN_SER | 6.80e-03 | 90 | 80 | 3 | IPR033116 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.76e-11 | 39 | 48 | 7 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.76e-11 | 39 | 48 | 7 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.21e-11 | 68 | 48 | 8 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.06e-09 | 143 | 48 | 9 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THBS1 CSF2RB ADAMTS3 ADAMTS7 SBSPON NCAN ADAMTS18 CFP SSPOP NOTCH4 | 9.30e-09 | 250 | 48 | 10 | M27554 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.72e-08 | 109 | 48 | 7 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 8.75e-08 | 111 | 48 | 7 | M27416 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.20e-05 | 42 | 48 | 4 | M7169 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.08e-05 | 63 | 48 | 4 | M11187 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.10e-04 | 161 | 48 | 5 | M39770 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.16e-04 | 43 | 48 | 3 | M53 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.02e-04 | 10 | 48 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.02e-04 | 10 | 48 | 2 | MM1560 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.11e-04 | 300 | 48 | 6 | M610 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 6.12e-04 | 11 | 48 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 7.33e-04 | 12 | 48 | 2 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 8.65e-04 | 13 | 48 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 8.65e-04 | 13 | 48 | 2 | M12950 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 9.53e-04 | 57 | 48 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.00e-03 | 58 | 48 | 3 | M2049 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.01e-03 | 14 | 48 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.01e-03 | 14 | 48 | 2 | M6487 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.05e-03 | 59 | 48 | 3 | M27218 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.16e-03 | 15 | 48 | 2 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.16e-03 | 15 | 48 | 2 | M27161 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.16e-03 | 61 | 48 | 3 | MM14637 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.46e-03 | 66 | 48 | 3 | M18 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.52e-03 | 67 | 48 | 3 | M26999 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.68e-03 | 18 | 48 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.68e-03 | 18 | 48 | 2 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.07e-03 | 20 | 48 | 2 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.07e-03 | 20 | 48 | 2 | MM15061 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.19e-03 | 76 | 48 | 3 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.19e-03 | 76 | 48 | 3 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.19e-03 | 76 | 48 | 3 | MM14867 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.74e-03 | 23 | 48 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.74e-03 | 23 | 48 | 2 | MM1427 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.01e-03 | 85 | 48 | 3 | M16441 | |
| Pubmed | CCN5 THBS1 HMCN1 ADAMTS3 ADAMTS7 ADAMTS18 PAPLN CFP ISM2 SSPOP | 2.83e-15 | 75 | 84 | 10 | 20637190 | |
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 10803852 | ||
| Pubmed | 4.97e-07 | 64 | 84 | 5 | 22261194 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21368163 | ||
| Pubmed | A butyrophilin family member critically inhibits T cell activation. | 5.76e-06 | 2 | 84 | 2 | 20944003 | |
| Pubmed | The ontogeny of Butyrophilin-like (Btnl) 1 and Btnl6 in murine small intestine. | 5.76e-06 | 2 | 84 | 2 | 27528202 | |
| Pubmed | Genome-wide meta-analysis identifies 3 novel loci associated with stroke. | 5.76e-06 | 2 | 84 | 2 | 30383316 | |
| Pubmed | 7.44e-06 | 16 | 84 | 3 | 31669249 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.59e-05 | 62 | 84 | 4 | 28344315 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 14676276 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 3025878 | ||
| Pubmed | Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. | 1.73e-05 | 3 | 84 | 2 | 15710885 | |
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 1.73e-05 | 3 | 84 | 2 | 34049963 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21059996 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21321940 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 16311602 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 32375678 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 20091789 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 30254632 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25111226 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25712208 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 3.45e-05 | 4 | 84 | 2 | 7827955 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 32724083 | ||
| Pubmed | Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. | 3.45e-05 | 4 | 84 | 2 | 27641500 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 20554900 | ||
| Pubmed | The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. | 3.45e-05 | 4 | 84 | 2 | 20709745 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 4.14e-05 | 79 | 84 | 4 | 18757743 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 29339503 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 9409248 | ||
| Pubmed | Cell adhesion molecules and extracellular-matrix constituents in kidney development and disease. | 5.74e-05 | 5 | 84 | 2 | 10547347 | |
| Pubmed | 6.82e-05 | 175 | 84 | 5 | 28071719 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 8.59e-05 | 6 | 84 | 2 | 9506531 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 7495302 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 2426947 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 21622854 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 8.59e-05 | 6 | 84 | 2 | 17513486 | |
| Pubmed | Chromosomal location of three unconventional myosin heavy chain genes in the mouse. | 8.59e-05 | 6 | 84 | 2 | 8954808 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 8.59e-05 | 6 | 84 | 2 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 8.59e-05 | 6 | 84 | 2 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 8.59e-05 | 6 | 84 | 2 | 6389236 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 8.59e-05 | 6 | 84 | 2 | 10534397 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 16041630 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 25122462 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 19118189 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 8.59e-05 | 6 | 84 | 2 | 9673377 | |
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 8.59e-05 | 6 | 84 | 2 | 3571333 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 8.59e-05 | 6 | 84 | 2 | 19275937 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 6988303 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 10639489 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.20e-04 | 7 | 84 | 2 | 8006028 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.20e-04 | 7 | 84 | 2 | 10716744 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 1724753 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 7521231 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 17418794 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 3997552 | ||
| Pubmed | Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. | 1.60e-04 | 8 | 84 | 2 | 29422532 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 1383086 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.60e-04 | 8 | 84 | 2 | 11867580 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.60e-04 | 8 | 84 | 2 | 10970885 | |
| Pubmed | 1.60e-04 | 210 | 84 | 5 | 16537572 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 8562707 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 10880400 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 8995276 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 9878537 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 12101409 | ||
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 9415455 | ||
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 11167130 | ||
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 9136074 | ||
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.13e-04 | 11 | 84 | 2 | 7500359 | |
| Pubmed | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | 3.13e-04 | 11 | 84 | 2 | 17339318 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.13e-04 | 11 | 84 | 2 | 9731539 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPN3 ADAMTS7 ZNF408 SORBS3 PKD1 FBRSL1 MAP3K11 PAPLN CACNA1H HR | 3.31e-04 | 1105 | 84 | 10 | 35748872 |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 26794322 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 3.75e-04 | 12 | 84 | 2 | 12180907 | |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 3.75e-04 | 12 | 84 | 2 | 15837576 | |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 16024816 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 3.75e-04 | 12 | 84 | 2 | 25770910 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 4.42e-04 | 13 | 84 | 2 | 9833687 | |
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 19542224 | ||
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 12878203 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 10625553 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 34927678 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 9264260 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 31494268 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 5.93e-04 | 15 | 84 | 2 | 10706142 | |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 5.93e-04 | 15 | 84 | 2 | 38871984 | |
| Pubmed | 6.77e-04 | 16 | 84 | 2 | 15878328 | ||
| Pubmed | 6.77e-04 | 16 | 84 | 2 | 30579834 | ||
| Pubmed | 7.34e-04 | 167 | 84 | 4 | 22159717 | ||
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 10464288 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 8.01e-04 | 171 | 84 | 4 | 20201926 | |
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 18501628 | ||
| Cytoband | 13q34 | 1.37e-04 | 54 | 84 | 3 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 3.37e-04 | 325 | 84 | 5 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 5.80e-04 | 88 | 84 | 3 | chr13q34 | |
| Cytoband | 9q34.3 | 9.95e-04 | 106 | 84 | 3 | 9q34.3 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.23e-05 | 19 | 53 | 3 | 50 | |
| GeneFamily | Proteases, serine | 8.34e-04 | 63 | 53 | 3 | 738 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 8.64e-04 | 15 | 53 | 2 | 458 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A3 CCN5 THBS1 HMCN1 SBSPON NCAN KCP PAPLN USH2A SSPOP | 1.31e-09 | 275 | 84 | 11 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 CCN5 THBS1 IL1F10 HMCN1 ADAMTS3 ADAMTS7 CLEC4A SBSPON NCAN WNT10B KCP ADAMTS18 PAPLN ISM2 USH2A SSPOP | 3.32e-09 | 1026 | 84 | 18 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 1.61e-08 | 270 | 84 | 10 | MM17057 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 CCN5 THBS1 IL1F10 HMCN1 ADAMTS3 ADAMTS7 CLEC4A SBSPON NCAN WNT10B KCP ADAMTS18 PAPLN ISM2 SSPOP | 1.74e-08 | 1008 | 84 | 17 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.81e-07 | 40 | 84 | 5 | M5887 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.27e-07 | 196 | 84 | 8 | M3008 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.76e-06 | 191 | 84 | 7 | MM17059 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 5.09e-06 | 136 | 84 | 6 | M2005 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 7.66e-06 | 146 | 84 | 6 | MM856 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.43e-06 | 186 | 84 | 6 | fccee4cfcc887358cf916d974f29627095b5ad9c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-06 | 195 | 84 | 6 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-06 | 195 | 84 | 6 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.28e-05 | 159 | 84 | 5 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-05 | 168 | 84 | 5 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.66e-05 | 168 | 84 | 5 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.76e-05 | 170 | 84 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-05 | 170 | 84 | 5 | 1c3c03821c90d41de92fef3278f71093a7fd709c | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-05 | 176 | 84 | 5 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.44e-05 | 182 | 84 | 5 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.51e-05 | 183 | 84 | 5 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 185 | 84 | 5 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 2.64e-05 | 185 | 84 | 5 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-05 | 187 | 84 | 5 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-05 | 187 | 84 | 5 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 2.78e-05 | 187 | 84 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 187 | 84 | 5 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 2.78e-05 | 187 | 84 | 5 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.85e-05 | 188 | 84 | 5 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-05 | 188 | 84 | 5 | fbf176b48b89c234e4e1e64739afc836bed78a96 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.85e-05 | 188 | 84 | 5 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.85e-05 | 188 | 84 | 5 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-05 | 189 | 84 | 5 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-05 | 189 | 84 | 5 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 2.93e-05 | 189 | 84 | 5 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-05 | 189 | 84 | 5 | e002dbb2138a6264be23f3b8148275a0cef351ef | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-05 | 189 | 84 | 5 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | Monocytes-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.93e-05 | 189 | 84 | 5 | 22d08c7dde697f385100f72e009eeac8d19d329d | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 3.00e-05 | 190 | 84 | 5 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 3.00e-05 | 190 | 84 | 5 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 190 | 84 | 5 | c408d4033a130c0168159a5b6f286fd2b2a9a39d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 190 | 84 | 5 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 3.08e-05 | 191 | 84 | 5 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 192 | 84 | 5 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 192 | 84 | 5 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 192 | 84 | 5 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.16e-05 | 192 | 84 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 192 | 84 | 5 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.23e-05 | 193 | 84 | 5 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.23e-05 | 193 | 84 | 5 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.40e-05 | 195 | 84 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-05 | 195 | 84 | 5 | 4e9513a7ea69fa9fc8e9ff2da8ef3f44e8fdc70d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 195 | 84 | 5 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-05 | 195 | 84 | 5 | a25a342380e258b784227f7298f609ccaa1f9ce7 | |
| ToppCell | (3)_MNP|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.48e-05 | 196 | 84 | 5 | c79403da5443710a6caf035a279e42bc324b27c9 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.57e-05 | 197 | 84 | 5 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.57e-05 | 197 | 84 | 5 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.57e-05 | 197 | 84 | 5 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 3.57e-05 | 197 | 84 | 5 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 3.57e-05 | 197 | 84 | 5 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-05 | 197 | 84 | 5 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.65e-05 | 198 | 84 | 5 | dbd7869483c5a67944cb94ced0ee2c7b999adc2e | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.65e-05 | 198 | 84 | 5 | 8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12 | |
| ToppCell | medial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.65e-05 | 198 | 84 | 5 | 432a26ace5b486695c9a933c0d44b73305b01ded | |
| ToppCell | (4)_Monocyte|World / shred on Cell_type and subtype | 3.65e-05 | 198 | 84 | 5 | 56f9ebf902fe81c590696ba4c88028deaf346841 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-05 | 198 | 84 | 5 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-05 | 198 | 84 | 5 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 3.74e-05 | 199 | 84 | 5 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.74e-05 | 199 | 84 | 5 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 199 | 84 | 5 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 36662a76211162b1bf2d58dc819cae339f715c5f | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 199 | 84 | 5 | 448dd5a27d57627468c6b8347f1b6b1005aea004 | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 199 | 84 | 5 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 199 | 84 | 5 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 199 | 84 | 5 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 3.74e-05 | 199 | 84 | 5 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | severe_influenza-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 3.74e-05 | 199 | 84 | 5 | b8adbd6ff5e5602259118a69fd7c77e8348a27e4 | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.83e-05 | 200 | 84 | 5 | b652bc73adfdeccbdcd74497ab6e2085e5c95e88 | |
| ToppCell | severe_influenza|World / disease group, cell group and cell class (v2) | 3.83e-05 | 200 | 84 | 5 | 2c965ec0c33a797c227a06dac90b5ecb959816f6 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 94d7aa057a31287696a634d15ce91ce64af6455b | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-05 | 200 | 84 | 5 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.83e-05 | 200 | 84 | 5 | c1345893e6947ccf9b41282d0e4428dbfb8bcc27 | |
| ToppCell | proximal-3-Epithelial-Alveolar_Epithelial_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.83e-05 | 200 | 84 | 5 | 51f8fc43c069f2c4e75588d28ae6deb5d7ed2c86 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.83e-05 | 200 | 84 | 5 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-05 | 200 | 84 | 5 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | (40)_Monocyte|World / shred on Cell_type and subtype | 4.41e-05 | 206 | 84 | 5 | d78a70f951265ef6df8f64404107be4f53e75d28 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 140 | 84 | 4 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 140 | 84 | 4 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 140 | 84 | 4 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 148 | 84 | 4 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 148 | 84 | 4 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.91e-04 | 151 | 84 | 4 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.91e-04 | 151 | 84 | 4 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-04 | 157 | 84 | 4 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 159 | 84 | 4 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 160 | 84 | 4 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 160 | 84 | 4 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 160 | 84 | 4 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-04 | 160 | 84 | 4 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.50e-04 | 162 | 84 | 4 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.62e-04 | 164 | 84 | 4 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.62e-04 | 164 | 84 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-myeloid_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | bfe330751d34813af7540765b490406078c40da7 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | 8bdeacbb47948fabae2575689f811a9fad47f779 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 166 | 84 | 4 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 166 | 84 | 4 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-04 | 166 | 84 | 4 | ce570b768988e30898cf0387c2aa99989631f13f | |
| Disease | Retinitis Pigmentosa | 1.97e-04 | 104 | 81 | 4 | C0035334 | |
| Disease | corneal topography | 2.36e-04 | 109 | 81 | 4 | EFO_0004345 | |
| Disease | asparaginase-induced acute pancreatitis | 2.65e-04 | 9 | 81 | 2 | EFO_1001507 | |
| Disease | Disorder of eye | 3.00e-04 | 212 | 81 | 5 | C0015397 | |
| Disease | myopathy (implicated_via_orthology) | 3.15e-04 | 48 | 81 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | neutrophil count | FLNB IL1F10 MYO1C EML6 PKD1 TNRC6A PCDHA11 RIOK3 PNPLA3 TARS2 ISM2 NOTCH4 | 3.77e-04 | 1382 | 81 | 12 | EFO_0004833 |
| Disease | collagen disease (implicated_via_orthology) | 4.83e-04 | 12 | 81 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | THBS1 IL1F10 ADAMTS7 NYNRIN NCAN ADAMTS18 PNPLA3 TARS2 NOTCH4 | 6.27e-04 | 869 | 81 | 9 | EFO_0004735 |
| Disease | non-high density lipoprotein cholesterol measurement | 7.62e-04 | 713 | 81 | 8 | EFO_0005689 | |
| Disease | level of triacylglycerol (56:6) in blood serum | 8.71e-04 | 16 | 81 | 2 | OBA_2020007 | |
| Disease | Diabetic Angiopathies | 8.71e-04 | 16 | 81 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 8.71e-04 | 16 | 81 | 2 | C0025945 | |
| Disease | saturated fatty acids to total fatty acids percentage | 1.51e-03 | 21 | 81 | 2 | EFO_0022305 | |
| Disease | mean platelet volume | 1.91e-03 | 1020 | 81 | 9 | EFO_0004584 | |
| Disease | Brain Diseases | 2.14e-03 | 25 | 81 | 2 | C0006111 | |
| Disease | total cortical area measurement | 2.23e-03 | 94 | 81 | 3 | EFO_0008381 | |
| Disease | Endogenous Hyperinsulinism | 2.32e-03 | 26 | 81 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.32e-03 | 26 | 81 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.32e-03 | 26 | 81 | 2 | C1257965 | |
| Disease | Encephalopathies | 2.50e-03 | 27 | 81 | 2 | C0085584 | |
| Disease | coronary artery disease (is_implicated_in) | 2.66e-03 | 100 | 81 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | Hyperinsulinism | 2.69e-03 | 28 | 81 | 2 | C0020459 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TCWEGPWQGRTLVPP | 541 | Q9HCM7 | |
| SSGWFPQPTAKWKGP | 156 | Q6UXE8 | |
| CPAFQLWPQWPGQSS | 1256 | Q5SNV9 | |
| KEPGPWGKACSLPMW | 86 | A0A096LP49 | |
| DIPPCPHGWISLWKG | 1566 | Q01955 | |
| SSGWFPRPTAKWKGP | 156 | Q6UX41 | |
| GSSWGPSADPWSPIP | 336 | Q9H201 | |
| ILPHQSPAWGPWGCK | 141 | Q8IVW1 | |
| SPAWGPWGCKDLSSG | 146 | Q8IVW1 | |
| CGPNVGLVWPWKSHP | 641 | Q96M86 | |
| TTTPSNWRPPGPWDQ | 81 | Q6Q4G3 | |
| CPPQWSLGPWSQCSK | 991 | Q8TE60 | |
| GPWSPSPWPSQAGRS | 1126 | Q9UKP4 | |
| QIPPCPSGWSSLWIG | 1566 | P02462 | |
| WWSATPTEGACAPGK | 721 | Q9Y5I1 | |
| AWPGWFLCGPAEPQQ | 116 | Q8WWZ1 | |
| TAGSWCLWPRVPAPP | 136 | Q6ZST4 | |
| QLATPPGWQATSPGW | 361 | Q9UJ55 | |
| PQKPTPEWEVACPWG | 1751 | Q6PRD1 | |
| PEWEVACPWGSVGPG | 1756 | Q6PRD1 | |
| LPDPGLCGPAWWAPS | 11 | Q02846 | |
| WGGPAAPASTSDPWP | 366 | O95208 | |
| TSDASLWTPPQGCPW | 266 | Q0VG99 | |
| LWTPPQGCPWTQSSP | 271 | Q0VG99 | |
| QGPFSSPKAWPEEWG | 486 | Q96JJ6 | |
| APGPWEKTPESWGPA | 1026 | Q96Q04 | |
| WTSWPACPPGLVHTL | 276 | O43593 | |
| GLCPDWESWDPQKPV | 181 | O75369 | |
| YEPQKEWSPWSPCSG | 326 | Q6H9L7 | |
| PEQDWPCWTPCSPKG | 421 | Q9NST1 | |
| WTSGAWSPPCPPSNA | 136 | Q7L5A3 | |
| ATGGLPWACPTSWLP | 86 | A8MTQ0 | |
| CDASPPWALWGRGPA | 46 | P36776 | |
| KEVPPGTKSSPGWSW | 441 | Q9UJY4 | |
| GWGPWEPCSVTCSKG | 141 | P27918 | |
| SDPCPTHGNWSPWSG | 4751 | Q96RW7 | |
| CPADWAWIVPPISGS | 441 | P29474 | |
| PPGASCWVLGWKEPQ | 706 | Q5K4E3 | |
| RNTWGPWPGTTQPPS | 261 | P0CG42 | |
| CNRVPCPAQWKTGPW | 961 | O15072 | |
| PSKWSPEVCWDSQPG | 226 | P32927 | |
| APLLGCWLQWGAPSP | 61 | Q9BQY9 | |
| CWLQWGAPSPGPLCL | 66 | Q9BQY9 | |
| PGPWKPTPSVSSASW | 356 | Q96JM3 | |
| RTKSSGWPPPSGTWG | 16 | Q14CM0 | |
| GVPCPEWSTAWGPCS | 191 | O76076 | |
| PKLNGSGPSWWPECT | 96 | Q92796 | |
| VWEAWTGTPGDCPPA | 116 | Q8NEP7 | |
| PWASWTCVKGPEVSG | 496 | Q6ZMW3 | |
| PKGPDTLWQCPSSPW | 896 | Q86VB7 | |
| SSPCAPWGPSGAWSS | 1126 | O95180 | |
| GPTWNLVCGDGWKVP | 116 | A6NKX4 | |
| PWDSWGSSRLPTQPG | 51 | Q3KP66 | |
| RACWAWGPSSPKPGE | 561 | Q16584 | |
| SWCWAVPGGSSKRGP | 1836 | P98161 | |
| LGVCPPWKAWTPGPA | 341 | Q9P2P1 | |
| LGNPAECWKNSSGPW | 1156 | A6NGG8 | |
| ESCGGKWPLWLSPFQ | 601 | Q9BW92 | |
| APSSWTWCRTGPAPP | 4721 | O75445 | |
| LLTAGPSSWPGEWGP | 306 | Q5JUK2 | |
| PPLWEQSAKLWGTGG | 261 | Q8IUW3 | |
| ALWKASKPGEPSWPC | 321 | P49589 | |
| SKPGEPSWPCPWGKG | 326 | P49589 | |
| CPGLLEACSWGPWGP | 4306 | A2VEC9 | |
| PGACPDSCQWSLWGP | 4611 | A2VEC9 | |
| SLWGPWSPCQVPCSG | 4621 | A2VEC9 | |
| LPWGSCNNPWNTPEC | 306 | Q9Y345 | |
| RCGWFSSWPPPSKSA | 81 | Q9UK53 | |
| PASPQCWGLGRAWPE | 91 | Q6ZWJ8 | |
| IVSWGAGCVQPWKPG | 781 | Q7RTY7 | |
| AGGKSSPEPWLWPPT | 556 | O14594 | |
| PGQSSLGLNTWWKAP | 691 | Q9ULL8 | |
| QGSIPCCFSWPLSWP | 326 | Q8NHU3 | |
| QGAWLGCPEPWEPLL | 1606 | Q99466 | |
| SPKRWGWNDVNCLGP | 211 | Q9UMR7 | |
| WPQPRGPACGSTAQW | 136 | Q8N910 | |
| PGTAAAWGPSKCPWA | 11 | O14730 | |
| AWGPSKCPWAIPQNT | 16 | O14730 | |
| TAGPQAGAPSPWPWE | 301 | Q2L4Q9 | |
| GLWPDKSEGCNRSWP | 66 | O00584 | |
| KDACPINGGWGPWSP | 486 | P07996 | |
| GPWPSWKQPDCLPTS | 631 | Q70EL4 | |
| PARPCFVGEWSPWSG | 71 | Q8IVN8 | |
| PETKRWKAGPWAPCS | 361 | O95428 | |
| WCVGDPLQPGLLWGP | 76 | Q9H9D4 | |
| AWYQTWPGPGSKPSA | 76 | O60504 | |
| PLWALDWCPVPEGAG | 396 | Q8WUA4 | |
| QLPSPGWSWDSQGPS | 306 | O95900 | |
| PSPGPQDTWEWGGCN | 186 | O00744 | |
| CSPSACLAPWWGQQP | 6 | Q6ZRP0 | |
| WGKPIDSGPSWGEPI | 1081 | Q8NDV7 | |
| WGKGEWKGSAAPSPT | 216 | Q9H5J0 | |
| KSLCPETWPTWAGRP | 676 | O00159 |